COPD: Investigating the gender paradigm shift

U.S. Pharmacist

Volumn 36, Issue 9, 2011, Pages 30-34

  Helms, Sheri L ^a   Ni, Fang Z ^a   Darbishire, Patricia L ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BUSPIRONE; CLONIDINE; CORTICOSTEROID; HORMONE; VARENICLINE;

ANXIETY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPRESSION; FEMALE; HUMAN; MALE; NICOTINE REPLACEMENT THERAPY; NOTE; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 80053201750     PISSN: 01484818     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Note

References (38)

1. American Lung Association. Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality. February 2010. www.lungusa.org/finding-cures/our-research/trend-reports/copd-trend-report.pdf. Accessed May 23, 2011
2. U.S. Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis of Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010
3. World Health Organization. Chronic obstructive pulmonary disease (COPD). Fact Sheet No. 315. February 2011. www.who.int/mediacentre/factsheets/fs315/en. Accessed May 23, 2011
4. National Institutes of Health. Fact Sheet. Chronic obstructive pulmonary disease (COPD). http://report.nih.gov/NIHfactsheets/ViewFactSheet.aspx?csid=77. Accessed May 26, 2011
5. World Health Organization. International classification of diseases (ICD). www.who.int/classifications/icd/en. Accessed May 23, 2011
6. Kochanek KD, Xu J, Murphy SL, et al. Deaths: preliminary data for 2009. National Vital Statistics Reports. Vol. 59, No 4. Hyattsville, MD: National Center for Health Statistics; 2011
7. U.S. Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. www.surgeongeneral.gov/library/smokingconsequences. May 27, 2004. Accessed May 26, 2011
8. Gritz ER. Cigarette smoking by adolescent females: implications for health and behavior. Women Health. 1984;9(2-3):103-115
9. Connett JE, Murray RP, Buist AS, et al. Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol. 2003;157:973-979
10. Chen Y, Horne SL, Dosman JA. Increased susceptibility to lung dysfunction in female smokers. Am Rev Respir Dis. 1991;143:1224-1230
11. Langhammer A, Johnsen R, Gulsvik A, et al. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J. 2003;21:1017-1023
12. Prescott E, Bjerg AM, Andersen PK, et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997;10:822-827
13. Gritz ER, Nielsen IR, Brooks LA. Smoking cessation and gender: the influence of physiological, psychological, and behavioral factors. J Am Med Womens Assoc. 1996;51:35-42
14. Perkins KA. Smoking cessation in women. Special considerations. CNS Drugs. 2001;15:391-411
15. Hibbert M, Lannigan A, Raven J, et al. Gender differences in lung growth. Pediatr Pulmonol. 1995;19:129-134
16. Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med. 2004;25:331-341
17. Carter R, Nicotra B, Huber G. Differing effects of airway obstruction on physical work capacity and ventilation in men and women with COPD. Chest. 1994;106:1730-1739
18. Silverman EK, Weiss ST, Drazen JM, et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162:2152-2158
19. Chiang K, Parthasarathy S, Santanam N. Estrogen, neutrophils and oxidation. Life Sci. 2004;75:2425-2438
20. Molloy EJ, O'Neill AJ, Grantham JJ, et al. Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone. Blood. 2003;102:2653-2659
21. Osman M. Therapeutic implications of sex differences in asthma and atopy. Arch Dis Child. 2003;88:587-590
22. Tan KS, McFarlane LC, Lipworth BJ. Modulation of airway reactivity and peak flow variability in asthmatics receiving the oral contraceptive pill. Am J Respir Crit Care Med. 1997;155:4:1273-1277
23. Balcells E, Gea J, Ferrar J, et al. Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes. 2010;8:108
24. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry. 2000;15:1090-1096
25. Mikkelsen RL, Middelboe T, Pisinger C, Stage, KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58:65-70
26. Gudmundsson G, Gislason T, Janson C, et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med. 2006;100:87-93
27. Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100:1767-1774
28. Katz PP, Julian LJ, Omachi TA, et al. The impact of disability on depression among individuals with COPD. Chest. 2010;137:838-845
29. Katsura H, Kida K. A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest. 2002;122:1949-1955
30. Kjensli A, Mowinckel P, Ryg MS, Falch JA. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone. 2007;40:493-497
31. Shane E, Silverberg SJ, Donovan D, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med. 1996;101:262-269
32. Hubbard RB, Smith CJ, Smeeth L, et al. Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med. 2002;166:1563-1566
33. Hatsukami D, Skoog K, Allen S, Bliss R. Gender and the effects of different doses of nicotine gum on tobacco withdrawal symptoms. Exp Clin Psychopharmacol. 1995;3:163-173
34. Wetter DW, Fiore MC, Young TB, et al. Gender differences in response to nicotine replacement therapy: objective and subjective indices of tobacco withdrawal. Exp Clin Psychopharmacol. 1999;7:135-144
35. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997;337:1195-1202
36. Chantix (varenicline) package insert. New York, NY: Pfizer Inc; December 2010
37. Cinciripini PM, Lapitsky L, Seay S, et al. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers. J Clin Psychopharmacol. 1995;15:182-191
38. Covey LS, Glassman AN. A meta-analysis of double-blind placebo-controlled trials of clonidine for smoking cessation. Br J Addict. 1991;86:991-998